Matthew Gordon

Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic SyndromesSchiller GJ, Slack J, Hainsworth JD, et al (Univ of California, Los Angeles; Univ of Southern California, Los Angeles; Scripps Cancer Ctr, San Diego, Calif; et al) J Clin Oncol 24:2456–2464, 2006§

Prognostic Value of Thrombocytosis in Renal Cell CarcinomaBensalah K, Leray E, Fergelot P, et al (Hôpital Pontchaillou, Rennes, France; CHU of Saint-Etienne, France) J Urol 175:859–863, 2006§

Antiangiogenic combination tumor therapy blocking αv-integrins and VEGF-receptor-2 increases therapeutic effects in vivoStrieth S, Eichhorn ME, Sutter A, et al (Ludwig-Maximilians-Univ, Munich; Merck KgaA, Darmstadt, Germany) Int J Cancer 119:423–431, 2006§

Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigationsAzzabi A, Hughes AN, Calvert PM, et al (Univ of Newcastle, Newcastle upon Tyne, England; Newcastle Gen Hosp, Newcastle upon Tyne, England, Princess Royal Hosp, Hull, England) Br J Cancer 92:1006–1012, 2005§

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialCohen AT for the ARTEMIS Investigators (Guy's, King's, and St Thomas' School of Medicine, London; et al) BMJ 332:325–327, 2006§

Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiolJick SS, Kaye JA, Russmann S, et al (Bosten Univ, Lexington, Mass) Contraception 73:223–228, 2006§

Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation modelBurroughs L, Mielcarek M, Little M-T, et al (Fred Hutchinson Cancer Research Ctr, Seattle; Univ of Washington, Seattle; AnorMED, Langley, BC, Canada) Blood 106:4002–4008, 2005§

Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane AntigenMa D, Hopf CE, Malewicz AD, et al (PSMA Development Co LLC, Tarrytown, NY; Seattle Genetics, Inc, Bothell, Wash) Clin Cancer Res 12:2591–2596, 2006§

Two Transforming C-RAF Germ-Line Mutations Identified in Patients with Therapy-Related Acute Myeloid LeukemiaZebisch A, Staber PB, Delavar A, et al (Med Univ of Graz, Austria; Innsbruck Med Univ, Austria) Cancer Res 66:3401–3408, 2006§

High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysisBrusky JP, Gailani F, Pathak A, et al (Kaiser Permanente, Los Angeles) B JU Int 97:279–280, 2006§